GILENYA®
Indications
Gilenya is indicated as monotherapy for the treatment of adult patients and paediatric patients of 10 years of age and above with the relapsing-remitting form of multiple sclerosis to reduce the frequency of clinical exacerbations and to delay the progression of physical disability.
GILENYA®
Rate this content:
No votes yet
FA-11236893, FA-11236897, FA-11236891